Dr. John Oertle of Envita Medical Centers Sheds Light on Non-Invasive Treatments for Prostate Cancer

Prostate cancer is the most diagnosed cancer in men and the second-leading cause of cancer deaths, highlighting the importance of timely screening and precision non-invasive treatments. Speaking to AZFamily, on Prostate Cancer Awareness Month, Dr. John Oertle, Chief Medical Director, Envita Medical Centers, said, “It shouldn't be a death sentence.”

His team at Envita has been able to successfully treat many late-stage prostate cancer patients, some of whom were left with limited options at other noted cancer treatment facilities in the country. Utilizing the personalized precision integrative oncology approach has been crucial to their success in their clinical experience of over two decades. “It's really important that once you are diagnosed that you do have an evaluation through genetic testing and precision medicine to be able to make sure that you are able to understand what kind of prostate cancer you have and what are the best ways to treat it,” added Dr. Oertle.

He explained how the specially trained team at Envita identifies the root causes of each patient's cancer to target the disease at its core, while also reactivating their immune system for lasting outcomes. “We do a lot of non-invasive treatments,” said Dr. Oertle, explaining how their proprietary precision oncology approach combines the latest in conventional medicine with advanced natural therapies.

To know more about advanced treatments for prostate cancers and ways to address its risk factors, watch this news report.